David Loew
Chief Executive Officer bij IPSEN
Vermogen: 59 562 $ op 31-03-2024
Profiel
David G. Loew is Chief Executive Officer & Director bij Ipsen SA en Chief Executive Officer bij Ipsen Pharma SAS (een dochteronderneming van Ipsen SA). In het verleden was hij Executive Vice President-Sanofi Pasteur bij Sanofi en Global Head-Product Strategy bij Genentech, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IPSEN SA
0.00% | 31-12-2022 | 500 ( 0.00% ) | 59 562 $ | 31-03-2024 |
Actieve functies van David Loew
| Bedrijven | Functie | Begin |
|---|---|---|
| IPSEN | Chief Executive Officer | 01-07-2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Chairman | 30-07-2020 |
| European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - |
| G5 Santé | Director/Board Member | - |
Eerdere bekende functies van David Loew
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 15-06-2020 |
| GAVI Alliance | Director/Board Member | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van David Loew
| University of St. Gallen | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SANOFI | Health Technology |
| IPSEN | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| GAVI Alliance | Miscellaneous |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| European Federation of Pharmaceutical Industries & Assoc | |
| G5 Santé |
